The nonprofit Alliance for Patient Access today released the results of a national survey of autoimmune patients on issues of COVID-19 vaccination, information sources and risk awareness. The survey report, "Autoimmune Disease & COVID-19 Information," summarizes 400 patients' responses, which were collected October 11-19, 2021. Participants included patients living with rheumatoid arthritis, multiple sclerosis, lupus, systemic sclerosis, Graves' disease and pemphigus.
Some medications for autoimmune diseases suppress the immune system, making patients more likely to develop serious illness if they contract COVID-19 and more likely to die from COVID-related complications. Not all patients recognize these risks or have clear information on how to protect themselves, however.
KEY FINDINGS
COVID-19 Risks
Only about half of patients reported being "very aware" that an initial vaccine regimen may not fully protect them and that they may need a third dose to improve their immune response.
STATEMENT FROM JOSIE COOPER, EXECUTIVE DIRECTOR, ALLIANCE FOR PATIENT ACCESS:
"Forty-one million Americans live with some form of autoimmune disease. We hope these survey results can help policymakers deliver what patients say they need: clear, trustworthy health and vaccine information that speaks to their specific patient population."
The report also featured on-the-ground insights from autoimmune patient advocacy organizations that participated in an online roundtable survey discussion hosted by the Alliance for Patient Access.
The report can be accessed online here.
The Alliance for Patient Access is a national network of policy-minded health care providers who advocate for patient-centered care and participate in clinician working groups, advocacy initiatives, stakeholder coalitions and the creation of educational materials.